Alexion Pharmaceuticals Business Systems Analyst Salaries in Boulder
The average Alexion Pharmaceuticals Business Systems Analyst in Boulder earns an estimated $89,066 annually, which includes an estimated base salary of $81,733 with a $7,333 bonus. Alexion Pharmaceuticals' Business Systems Analyst compensation is $5,595 more than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Alexion Pharmaceuticals in Boulder can range from $54,000 - $155,000.
In Boulder, The Operations Department at Alexion Pharmaceuticals earns $3,966 more on average than the Admin Department.
Last updated 2 years ago.
- $81,733
- avg. base
- $7,333
- avg. bonus
Business Systems Analyst Salaries at Alexion Pharmaceuticals
In Boulder, Business Systems Analysts earn $2,476 more than Business Analysts, and $18,376 less than Operations Managers.
Compensation at Alexion Pharmaceuticals by Department
In Boulder, The Operations Department averages $3,966 more than the Admin Department, and $23,754 less than the Business Development Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Alexion Pharmaceuticals reported making $87,169, while the average male Business Systems Analyst at similar sized companies reported making $87,647.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Business Systems Analyst at companies similar size to Alexion Pharmaceuticals reported making $93,453, while the average African American/Black Business Systems Analyst at similar sized companies reported making $80,590.
How Business Systems Analysts at Alexion Pharmaceuticals Rate Their Compensation
The majority of Business Systems Analysts at Alexion Pharmaceuticals believe they're compensated fairly. 100% of Business Systems Analysts at Alexion Pharmaceuticals say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Alexion Pharmaceuticals
